Clinical trials: Recurrent Implantation Faliure, open to volunteers
Recurrent Implantation Faliure
Thymosin-α1 for Recurrent Implantation Failure
Clinical trial evaluating the safety and efficacy of Thymosin-α1 (Tα1) as an adjunctive immunomodulatory therapy in women with unexplained recurrent implantation failure (RIF) undergoing IVF/ICSI cycles.
- Trial name
- Thy-α1 for RIF (NCT07675980)
- Testing
- Thymosin Alpha1
- Where
- United Arab Emirates
- Volunteers
- 136 people
- Sponsor
- Fakih IVF Fertility Center